Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 233

1.

Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy.

Roscoe JA, Morrow GR, Hickok JT, Mustian KM, Griggs JJ, Matteson SE, Bushunow P, Qazi R, Smith B.

Breast Cancer Res Treat. 2005 Feb;89(3):243-9.

PMID:
15754122
[PubMed - indexed for MEDLINE]
2.

Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program.

Morrow GR, Hickok JT, Roscoe JA, Raubertas RF, Andrews PL, Flynn PJ, Hynes HE, Banerjee TK, Kirshner JJ, King DK; University of Rochester Cancer Center Community Clinical Oncology Program.

J Clin Oncol. 2003 Dec 15;21(24):4635-41.

PMID:
14673053
[PubMed - indexed for MEDLINE]
3.

Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment.

Roscoe JA, Morrow GR, Hickok JT, Bushunow P, Matteson S, Rakita D, Andrews PL.

Support Care Cancer. 2002 May;10(4):329-36. Epub 2001 Nov 28.

PMID:
12029433
[PubMed - indexed for MEDLINE]
4.

A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors.

Stearns V, Isaacs C, Rowland J, Crawford J, Ellis MJ, Kramer R, Lawrence W, Hanfelt JJ, Hayes DF.

Ann Oncol. 2000 Jan;11(1):17-22.

PMID:
10690382
[PubMed - indexed for MEDLINE]
Free Article
5.

A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.

Musselman DL, Somerset WI, Guo Y, Manatunga AK, Porter M, Penna S, Lewison B, Goodkin R, Lawson K, Lawson D, Evans DL, Nemeroff CB.

J Clin Psychiatry. 2006 Feb;67(2):288-96.

PMID:
16566626
[PubMed - indexed for MEDLINE]
6.

A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer.

Weitzner MA, Moncello J, Jacobsen PB, Minton S.

J Pain Symptom Manage. 2002 Apr;23(4):337-45.

PMID:
11997203
[PubMed - indexed for MEDLINE]
7.

Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine.

Baldwin D, Bridgman K, Buis C.

J Psychopharmacol. 2006 Jan;20(1):91-6. Epub 2005 Oct 4.

PMID:
16204325
[PubMed - indexed for MEDLINE]
8.

Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy.

Navari RM, Brenner MC, Wilson MN.

Breast Cancer Res Treat. 2008 Nov;112(1):197-201. Epub 2007 Dec 7.

PMID:
18064563
[PubMed - indexed for MEDLINE]
9.

Effect of exercise on biomarkers, fatigue, sleep disturbances, and depressive symptoms in older women with breast cancer receiving hormonal therapy.

Payne JK, Held J, Thorpe J, Shaw H.

Oncol Nurs Forum. 2008 Jul;35(4):635-42. doi: 10.1188/08.ONF.635-642.

PMID:
18591167
[PubMed - indexed for MEDLINE]
10.

Ejaculation-retarding properties of paroxetine in patients with primary premature ejaculation: a double-blind, randomized, dose-response study.

Waldinger MD, Hengeveld MW, Zwinderman AH.

Br J Urol. 1997 Apr;79(4):592-5.

PMID:
9126089
[PubMed - indexed for MEDLINE]
11.

A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure.

Gottlieb SS, Kop WJ, Thomas SA, Katzen S, Vesely MR, Greenberg N, Marshall J, Cines M, Minshall S.

Am Heart J. 2007 May;153(5):868-73.

PMID:
17452166
[PubMed - indexed for MEDLINE]
12.

[A double-blind comparative study of the effectiveness and tolerance of paroxetine and amitriptyline in treatment of breast cancer patients with clinically assessed depression].

Möslinger-Gehmayr R, Zaninelli R, Contu A, Oberhoff C, Gutschow K, Schindler AE, Staab HJ.

Zentralbl Gynakol. 2000;122(4):195-202. German. Erratum in: Zentralbl Gynakol 2000;122(7):389.

PMID:
10795116
[PubMed - indexed for MEDLINE]
13.

Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis.

Ehde DM, Kraft GH, Chwastiak L, Sullivan MD, Gibbons LE, Bombardier CH, Wadhwani R.

Gen Hosp Psychiatry. 2008 Jan-Feb;30(1):40-8. doi: 10.1016/j.genhosppsych.2007.08.002.

PMID:
18164939
[PubMed - indexed for MEDLINE]
14.

Impact of paroxetine on sleep problems in 426 cancer patients receiving chemotherapy: a trial from the University of Rochester Cancer Center Community Clinical Oncology Program.

Palesh OG, Mustian KM, Peppone LJ, Janelsins M, Sprod LK, Kesler S, Innominato PF, Roth T, Manber R, Heckler C, Fiscella K, Morrow GR.

Sleep Med. 2012 Oct;13(9):1184-90. doi: 10.1016/j.sleep.2012.06.001. Epub 2012 Aug 2.

PMID:
22858235
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

[Clinical effectiveness and safety of paroxetine in post-stroke depression: results from a phase 4, open label, multicenter clinical trial with 26 weeks of follow-up].

Horváth S, Karányi Z, Harcos P, Nagy Z, Németh G, Andor G.

Orv Hetil. 2006 Dec 17;147(50):2397-404. Hungarian.

PMID:
17274185
[PubMed - indexed for MEDLINE]
16.

Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline.

Pezzella G, Moslinger-Gehmayr R, Contu A.

Breast Cancer Res Treat. 2001 Nov;70(1):1-10.

PMID:
11766999
[PubMed - indexed for MEDLINE]
17.

Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial.

Stearns V, Slack R, Greep N, Henry-Tilman R, Osborne M, Bunnell C, Ullmer L, Gallagher A, Cullen J, Gehan E, Hayes DF, Isaacs C.

J Clin Oncol. 2005 Oct 1;23(28):6919-30. Erratum in: J Clin Oncol. 2005 Nov 20;23(33):8549.

PMID:
16192581
[PubMed - indexed for MEDLINE]
Free Article
18.

Paroxetine for the prevention of depression induced by high-dose interferon alfa.

Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna S, Goodkin RS, Greiner K, Nemeroff CB, Miller AH.

N Engl J Med. 2001 Mar 29;344(13):961-6.

PMID:
11274622
[PubMed - indexed for MEDLINE]
Free Article
19.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
[PubMed - indexed for MEDLINE]
20.

Accelerating symptom-reduction in late-life depression: a double-blind, randomized, placebo-controlled trial of sleep deprivation.

Reynolds CF 3rd, Smith GS, Dew MA, Mulsant BH, Miller MD, Schlernitzauer M, Stack JA, Houck PR, Pollock BG.

Am J Geriatr Psychiatry. 2005 May;13(5):353-8.

PMID:
15879583
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk